BLRD Research Career Scientist Award Application

BLRD 研究职业科学家奖申请

基本信息

  • 批准号:
    10481027
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2029-03-31
  • 项目状态:
    未结题

项目摘要

This proposed Research Career Scientist award is to support the activities of Dr. Nihal Ahmad, an established Department of Veterans Affairs (VA) investigator, allowing him to expand his scientific, mentoring and service contributions. Dr. Ahmad’s long-term goal is to improve the quality of human life, including that of Veterans, through my research. Dr. Ahmad’s laboratory focuses on two broad and complementary research areas: 1) cancer biology and 2) prevention and experimental therapeutics of cancer. The major goal of his ongoing research is to define the critical molecular and biochemical events that occur during cancer development and progression to help identify novel targets and strategies for cancer management. While Dr. Ahmad’s laboratory is involved in understanding epithelial cancer in general, his major recent focus has been on skin- and prostate- cancers, both of which disproportionally affect the Veteran population. Dr. Ahmad’s current VA sponsored research focuses on identifying the mechanism of melanoma development and progression. Importantly, melanoma is among the five most frequently diagnosed cancers among VA cancer patients. In addition, the US military engages in missions all over the world, including recently in the Middle East (Iraq and Afghanistan). Deployment to these regions is associated with significant UV radiation exposure that increases the risk for malignant melanoma in the Veterans returning from these areas. Thus, Dr. Ahmad’s research findings may lead to identification of novel strategies for the management of this deadly neoplasm; and is relevant and significant to the health care of Veterans and directly in line with the mission of the Department of Veterans Affairs. The results of Dr. Ahmad’s research are published in a wide range of high-impact scientific journals. He has published more than 208 papers, 176 published abstracts and several book chapters (I have published more than 208 papers, 176 published abstracts and several book chapters (Total Citations: 28,413; h-index, 83; i10-index: 172; Source: Google Scholar; 08/2021). Dr. Ahmad is internationally recognized researcher. He serves as an Associate Editor of multiple well- respected journals, namely Toxicology and Applied Pharmacology, Journal of Oncology, Journal of Skin Cancer, and Frontiers in Oncology and Photochemistry and Photobiology, and he is a member of the Editorial Board for several other journals. He is regularly invited to participate in the peer-review of grants for national and international funding agencies, including the National Institutes of Health and the Department of Defense. He has recently completed his term as a Charter Member of the Radiation Therapeutics and Biology (RTB) Study Section of the NIH. In addition, he has mentored numerous junior scientists at all levels (undergraduate, graduate, post-doctoral, and junior faculty). Most of his previous trainees/mentees have been successful in obtaining independent positions in academia and industry. In addition, Dr. Ahmad has developed extensive collaborations with numerous scientists within the VA and at the University of Wisconsin, other universities in the US, and outside the country (internationally). Most of his collaborations have been very successful resulting in numerous papers and extramural funding.
这项拟议的研究职业科学家奖是为了支持博士的活动。 成立退伍军人事务部(VA)调查员,使他能够扩大他的科学,指导 服务贡献。艾哈迈德博士的长期目标是提高人类生活质量,包括 退伍军人,通过我的研究。艾哈迈德博士的实验室专注于两个广泛和互补的研究 领域:1)癌症生物学和2)癌症的预防和实验治疗。他的主要目标是 目前正在进行的研究是确定癌症发生过程中的关键分子和生物化学事件, 发展和进步,以帮助确定新的目标和癌症管理的战略。虽然博士。 Ahmad的实验室参与了对上皮癌的总体了解,他最近的主要关注点是 皮肤癌和前列腺癌,这两种癌症都会对退伍军人产生不良影响。 艾哈迈德博士目前的VA赞助的研究重点是确定黑色素瘤的机制 发展和进步。重要的是,黑色素瘤是五种最常见的癌症之一, 在退伍军人管理局癌症患者中此外,美军在世界各地从事任务,包括 最近在中东(伊拉克和阿富汗)。部署到这些地区, 紫外线辐射暴露,增加了从这些退伍军人返回恶性黑色素瘤的风险 地区因此,艾哈迈德博士的研究结果可能会导致识别新的战略管理 这种致命的肿瘤;是相关的和重要的退伍军人的医疗保健,并直接符合 退伍军人事务部的使命。艾哈迈德博士的研究结果发表在广泛的 高影响力的科学期刊。发表论文208篇,摘要176篇, 几本书的章节(我已发表超过208篇论文、176篇出版摘要和几本书 章节(总引文:28,413; h-index,83; i10-index:172;来源:Google Scholar; 08/2021)。 艾哈迈德博士是国际公认的研究员。他是一位优秀的编辑, 受人尊敬的期刊,即《毒理学与应用药理学》、《肿瘤学杂志》、《皮肤杂志》 癌症,肿瘤学和光化学和光生物学前沿,他是编辑部成员 其他几家期刊的董事会。他经常应邀参加国家赠款的同行审查。 以及国际资助机构,包括美国国立卫生研究院和国防部。 他最近完成了他作为放射治疗和生物学(RTB)特许会员的任期。 美国国立卫生研究院研究科。此外,他还指导了许多各级(本科, 研究生、博士后和初级教师)。他以前的大多数学员/学员都成功地在 在学术界和工业界获得独立地位。此外,艾哈迈德博士还开发了广泛的 与弗吉尼亚州和威斯康星州大学的众多科学家合作, 美国和国外(国际)。他的大部分合作都非常成功 导致了大量的论文和校外资金。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nihal Ahmad其他文献

Nihal Ahmad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nihal Ahmad', 18)}}的其他基金

Combined inhibition of PLK1 and NOTCH for melanoma management
联合抑制 PLK1 和 NOTCH 治疗黑色素瘤
  • 批准号:
    10481129
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Functional and Therapeutic Significance of PLK4 in Melanoma
PLK4 在黑色素瘤中的功能和治疗意义
  • 批准号:
    10442947
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10593106
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Functional and Therapeutic Significance of PLK4 in Melanoma
PLK4 在黑色素瘤中的功能和治疗意义
  • 批准号:
    10671687
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Role of sirtuin 6 in melanoma development and progression
Sirtuin 6 在黑色素瘤发生和进展中的作用
  • 批准号:
    10426079
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Role of sirtuin 6 in melanoma development and progression
Sirtuin 6 在黑色素瘤发生和进展中的作用
  • 批准号:
    10595641
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    10046297
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    9551225
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    10421255
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    9898255
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了